RankAlpha logo
Back to Rankings

ENTX

Entera BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ENTX vs peer average
48/100
ENTX vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · D 4 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ATOS is the first available peer comparator.

Loose same-sector, similar-market-cap biotech comparator from the packet; useful only for financing sensitivity and binary clinical-event volatility, not as a direct osteoporosis or oral-peptide peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerATOSAtossa Therapeutics
ENTX
Entera Bio
ATOS
Atossa Therapeutics
Grade
D
F
Momentum
91
2
Value
41
58
Sentiment
3
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ATOS

ENTX / ATOS
Grade Position
In line
ENTX vs. peer average (D vs. D)
48/100
Momentum
91
ENTX
Value
41
ATOS
Sentiment
3
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENTX
1
ATOS
ATOS
F
20/100
+1
2
PLRX
PLRX
A
100/100
-3
3
BMEA
Biomea Fusion Inc Common
D
40/100
Even
4
BTMD
biote Corp Class A Common
D
40/100
Even
5
RANI
Rani Therapeutics Holdings Inc Class A Common
B
80/100
-2
ATOS is the first peer returned for this comparison set.